The use of natural products in colorectal cancer drug discovery

Expert Opinion on Drug Discovery
Koh MiuraTsuneaki Fujiya

Abstract

Natural products (NPs) are evolutionarily designed and contain more complex and challenging structures than synthetic compounds. Since the 1980s, the pharmaceutical industry has gradually shifted to a strategy of developing targeted agents by screening libraries of synthetic compounds. However, NPs have recently received renewed focus as a rich repository for drug discovery. Irinotecan was developed as a derivative of camptothecin and was applied in standard regimens for metastatic colorectal cancer (CRC) worldwide. Additionally, polysaccharide K is approved for CRC in Japan and Taiwan in combination with cytotoxic agents. However, after the approval of irinotecan in 1996, no anti-cancer agents derived from NPs have been approved for CRC. This review discusses NPs that are currently under investigation for the treatment of CRC. In addition, other NPs derived as purified ingredients and crude extracts are listed and also discussed. The use of NPs for the discovery of anti-cancer agents has not been fully investigated. New technologies that are currently applied for synthetic compounds may be utilized for anti-cancer drug discovery including NPs for CRC.

References

Jun 6, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·David J BoocockDean E Brenner
Jan 15, 2008·British Journal of Pharmacology·A ChiccaP Nieri
Apr 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ajaikumar B KunnumakkaraSunil Krishnan
Jun 19, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Shaiju K VareedDean E Brenner
Dec 5, 2008·Expert Opinion on Investigational Drugs·Judith R Kroep, Hans Gelderblom
Jan 24, 2009·Biochemical Pharmacology·Christian Bailly
Jul 8, 2009·Drug Discovery Today·Wilfried Weber, Martin Fussenegger
Jul 9, 2009·Cancer Prevention Research·Sarah ThomassetAndreas J Gescher
Jul 11, 2009·Organic & Biomolecular Chemistry·Kirstin Scherlach, Christian Hertweck
Jul 23, 2009·International Journal of Cancer. Journal International Du Cancer·Ajaikumar B KunnumakkaraBharat B Aggarwal
Aug 8, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Harvey J MurffWei Zheng
Sep 9, 2009·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·M Rusconi, A Conti
Sep 9, 2009·International Journal of Radiation Oncology, Biology, Physics·Santosh K SandurSunil Krishnan
Oct 16, 2009·Journal of Medicinal Chemistry·Frank LoveringChristine Humblet
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerSuzanne L Topalian
Jun 23, 2010·Journal of the American Chemical Society·Vlado DancíkPaul A Clemons
Aug 20, 2010·Science Translational Medicine·Wing LamYung-Chi Cheng
Sep 15, 2010·International Journal of Cancer. Journal International Du Cancer·Lynne M HowellsKaren Brown
Oct 15, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Xiang-jian LuoYa Cao
Oct 30, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lucia FiniLuigi Ricciardiello
Nov 12, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hailing LuMary L Disis
Feb 5, 2011·Journal of Medicinal Chemistry·Wen ZhangChunming Liu
Mar 5, 2011·Cancer Prevention Research·Robert E CarrollDean E Brenner
May 4, 2011·Molecular Nutrition & Food Research·Masahito ShimizuHisataka Moriwaki
Jun 21, 2011·Current Opinion in Chemical Biology·Esther K SchmittFrank Petersen
Jun 21, 2011·Current Opinion in Chemical Biology·Wayne Mitchell
Jun 21, 2011·Current Opinion in Chemical Biology·Gemma L Thomas, Charles W Johannes
Jul 5, 2011·Current Opinion in Chemical Biology·Wayne Mitchell, Shunji Matsumoto
Feb 7, 2012·Journal of Biotechnology·Matias D ZurbriggenWilfried Weber

❮ Previous
Next ❯

Citations

Apr 14, 2016·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Junxian YuRuiwen Zhang
Aug 25, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Joo-Eun LeeHee Min Yoo
Feb 10, 2021·Journal of Enzyme Inhibition and Medicinal Chemistry·Heping ZhuYuanjiang Pan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Medical Letter on Drugs and Therapeutics
Gan to kagaku ryoho. Cancer & chemotherapy
Satoru Iwasa, Yasuhiro Shimada
Expert Opinion on Biological Therapy
Teresa MacarullaJosep Tabernero
© 2022 Meta ULC. All rights reserved